|
* U.S. stocks fell on Friday after the December
jobs report painted a mixed picture of the economy, giving the
benchmark S&P index its second straight weekly decline. Since
hitting a record high on Dec. 29, the index has fallen 2.2
percent on concerns about global growth and falling oil prices.
* Fourth-quarter earnings are expected to grow by 4 percent over
the year-ago period, according to Thomson Reuters data.
* Alcoa is scheduled to post quarterly earnings after the
closing bell, with financials JPMorgan Chase, Wells Fargo,
Goldman Sachs and Citigroup due to report later in the week. Dow
component Intel Corp is expected to post earnings on Thursday.
* NPS Pharmaceuticals jumped 8.7 percent to $45.55 in premarket
trading after Shire Plc agreed to acquire the company for $5.2
billion. U.S.-listed shares of Shire fell 1.6 percent to $214.
* Foundation Medicine surged 106.1 percent to $49.31 after Roche
Holding agreed to take a majority stake in the company for up to
$1.18 billion.
* Johnson & Johnson boosted its research efforts in Alzheimer's
by striking a deal potentially worth up to $509 million with
unlisted Swiss biotech firm AC Immune to develop so-called anti-tau
vaccines.
* Bristol-Myers Squibb climbed 5.6 percent to $63.68 in
premarket trade after the company said the independent data
monitoring committee concluded that a late stage study
evaluating its Opdivo lung cancer drug met its endpoint.
Futures snapshot at 7:24 a.m.:
* S&P 500 e-minis were up 10.25 points, or 0.5 percent, with
111,160 contracts changing hands.
* Nasdaq 100 e-minis were up 21 points, or 0.5 percent, in
volume of 20,029 contracts.
* Dow e-minis were up 85 points, or 0.48 percent, with 20,211
contracts changing hands.
(Reporting by Chuck Mikolajczak; Editing by Bernadette Baum)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
